Marinna Madrid is a co-founder at Cellino, a venture capital-backed early-stage biotech company. Cellino is making personalized regenerative medicines economically viable at scale for the first time. Marinna received her PhD and MA in Applied Physics from Harvard University, where she co-invented laser-based intracellular delivery techniques. She received her BSc in Biophysics from University of California, Los Angeles, after transferring from Riverside Community College. She is the recipient of the Harvard Graduate Prize Fellowship, the Catalyst Accelerator Grant from Harvard Medical School, and is on the Forbes 30 Under 30 2019 list for Healthcare.

© 2021 BioFutureTM. All Rights Reserved

Produced by